Patents by Inventor Diego Chowell Puente

Diego Chowell Puente has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HLA CLASS I SEQUENCE DIVERGENCE AND CANCER THERAPY
    Publication number: 20220389102
    Abstract: Molecular determinants of cancer response to immunotherapy are described.
    Type: Application
    Filed: October 30, 2020
    Publication date: December 8, 2022
    Inventors: Timothy A. Chan, Diego Chowell Puente, Chirag Krishna, Tobias Leander Lenz, Federica Pierini
  • TUMOR MUTATIONAL LOAD
    Publication number: 20220340663
    Abstract: The present invention encompasses the discovery that the likelihood of a favorable response to cancer immunotherapy for a wide range of different cancers can be predicted through definition of a tumor mutational load threshold for the tumor (and/or the relevant immunotherapy).
    Type: Application
    Filed: November 29, 2021
    Publication date: October 27, 2022
    Inventors: Timothy A. Chan, Diego Chowell Puente, Robert M. Samstein, Luc Morris
  • Tumor mutational load
    Patent number: 11230599
    Abstract: The present invention encompasses the discovery that the likelihood of a favorable response to cancer immunotherapy for a wide range of different cancers can be predicted through definition of a tumor mutational load threshold for the tumor (and/or the relevant immunotherapy).
    Type: Grant
    Filed: September 25, 2018
    Date of Patent: January 25, 2022
    Assignee: Memorial Sloan Kettering Cancer Center
    Inventors: Timothy A. Chan, Diego Chowell Puente, Robert M. Samstein, Luc Morris